查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1842132

美国人口健康管理市场：市场规模、份额、趋势分析（按产品、交付方式、最终用途和地区划分）、细分市场预测（2025-2033 年）

U.S. Population Health Management Market Size, Share & Trends Analysis Report By Product (Software, Services), By Delivery Mode (On-Premise, Cloud-based), By End Use (Providers, Payers, Employer Groups), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国人口健康管理：市场概览

2024 年美国人口健康管理市场规模估计为 360.4 亿美元，预计到 2033 年将达到 2,101.8 亿美元，2025 年至 2033 年的复合年增长率为 21.70%。

市场成长的主要驱动力是医疗保健 IT 服务和解决方案的需求不断增长，这些服务和解决方案支援基于价值的医疗保健服务，而这种需求增长是由按服务收费 (FFS) 模式向基于价值的支付 (VBP) 模式的转变所驱动的。

医疗保健支出不断增长、对以价值为导向的医疗服务需求日益增加，以及在各种医疗环境中进行有效的疾病管理，预计将推动美国人口健康管理行业的成长。美国有超过1.3亿人至少有一种慢性疾病。例如，根据美国疾病管制与预防中心（CDC）2024年2月发布的数据，估计美国有1.29亿人患有至少一种重大慢性疾病。

基于开放应用程式介面 (API) 的人口健康管理解决方案有助于管理治疗成本高昂的慢性疾病，例如心臟疾病、气喘和糖尿病。人口健康管理解决方案还有助于降低治疗成本并改善患者预后。此外，人口健康管理软体还能更好地分析患者数据，从而做出更明智的决策。

此外，实施人群健康管理 (PHM) 可以透过帮助识别高风险患者并加强疾病预防和管理，从而节省金钱。为了鼓励采用 PHM 系统，美国医疗保险和医疗补助服务中心 (CMS) 推出了基于价值的支付调整方案，该方案根据医生提供的医疗服务品质而非绩效期内产生的医疗费用，为医生群体提供不同的支付标准。

在美国，医疗服务提供者、支付者和责任医疗组织正在推动病患健康管理（PHM）系统的发展。许多医疗服务提供者和支付方需要升级和自动化其医疗管理系统，这有望改善医疗服务和部门间协作。医疗服务提供者主要关注糖尿病和心血管疾病等慢性病，这些疾病通常会造成巨大的医疗成本。文明病的增加，使得医疗中心更需要有效管理疾病负担。

此外，主要企业正在采取策略性倡议，例如推出新产品、建立合作伙伴关係、併购活动，这些倡议都有助于市场成长。例如，2025年5月，Oracle、克利夫兰诊所和G42宣布建立策略伙伴关係，共同开发一个基于人工智慧的全球医疗保健平台。该平台将利用人工智慧、大数据分析和临床专业知识，在美国和阿联酋提升患者疗效、精准医疗和人群健康管理水平，并提供可扩展且经济实惠的医疗服务模式。

目录

第一章 分析方法和范围

第二章执行摘要

3. 人口健康管理市场：变数、趋势和范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 人口健康管理市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析

第四章美国人口健康管理市场：按产品分類的估算与趋势分析

  • 分段定义
  • 按产品分類的变化分析和市场份额（2024 年和 2033 年）
  • 美国人口健康管理市场：产品概览
  • 依产品划分（2021-2033 年）
    • 软体
    • 服务

第五章美国人口健康管理市场：按交付方式分類的估算与趋势分析

  • 分段定义
  • 按交付方式分類的变化分析和市场份额（2024 年和 2033 年）
  • 美国人口健康管理市场：交付方式概览
  • 按供给法（2021-2033 年）
    • 本地部署
    • 云端基础的

第六章美国人口健康管理市场：依最终用途分類的估算与趋势分析

  • 分段定义
  • 按最终用途分類的变化分析和市场份额（2024 年和 2033 年）
  • 美国人口健康管理市场：终端用户仪錶板
  • 依最终用途划分（2021-2033 年）
    • 医疗保健提供者
    • 付款人
    • 雇主团体

第七章美国人口健康管理市场：竞争分析

  • 参与企业概况
  • 财务业绩
  • 产品基准测试
  • 公司分类
  • 企业市场分析
  • 公司简介
    • Veradigm LLC
    • Oracle
    • Conifer Health Solutions, LLC
    • eClinicalWorks
    • Enli Health Intelligence
    • McKesson Corporation
    • Medecision
    • Optum, Inc.
    • Advisory Board
    • Koninklijke Philips NV
    • athenahealth, Inc.
    • RedBrick Health
    • Welltok
Product Code: GVR-2-68038-458-1

U.S. Population Health Management Market Summary

The U.S. population health management market size was estimated at USD 36.04 billion in 2024 and is projected to reach USD 210.18 billion by 2033, growing at a CAGR of 21.70% from 2025 to 2033. The market growth is majorly driven by the rising demand for healthcare IT services and solutions that support value-based healthcare delivery, resulting in a transition from Fee-For-Service (FFS) to a Value-Based Payment (VBP) model.

Increasing healthcare expenditure, the rising need for value-based healthcare, and effective disease management across different care settings are expected to drive the growth of the U.S. population health management industry. More than 130 million people in the U.S. suffer from at least one chronic condition. For instance, according to the data published by the Centers for Disease Control and Prevention (CDC) in February 2024, an estimated 129 million people in the U.S. live with at least one major chronic disease.

Population health management solutions based on open Application Programming Interfaces (APIs) are helpful for the management of chronic conditions with high treatment costs, such as cardiac diseases, asthma, and diabetes. PHM solutions also help reduce the cost of care, improve patient outcomes. PHM software also enables better analysis of patient data to make informed decisions.

Moreover, the implementation of population health management (PHM) facilitates the identification of at-risk patients and enhances disease prevention and management, resulting in financial savings. The Centers for Medicare & Medicaid Services (CMS) has introduced the Value-Based Payment Modifier to promote the adoption of PHM systems. This modifier offers varying payment rates to physician groups based on the quality of care provided, rather than the cost of care incurred during their performance period.

In the U.S., providers, payers, and accountable care organizations promote PHM systems. Many providers and payers require upgrading and automating their healthcare management systems, which is anticipated to improve healthcare delivery and help departments collaborate. The providers mainly focus on chronic diseases, such as diabetes and cardiovascular disorders, which are generally responsible for significant healthcare costs. The rising prevalence of lifestyle disorders has increased the need for effective management of the disease burden on healthcare centers.

Furthermore, key players are engaged in strategic initiatives, such as the launch of new products, partnerships and collaborations, mergers and acquisition activities, etc., which contribute to market growth. For instance, in May 2025, Oracle, the Cleveland Clinic, and G42 announced a strategic partnership to develop an AI-based global healthcare platform. This platform will leverage AI, large-scale data analytics, and clinical expertise to deliver scalable, affordable care models, enhancing patient outcomes, precision medicine, and public health management across the U.S. and UAE.

U.S. Population Health Management Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. population health management market report based on product, delivery mode, and end use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Services
  • Delivery Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • On-Premise
  • Cloud-based
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Providers
  • Payers
  • Employer Groups

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Delivery Mode Segment
    • 1.2.3. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Population Health Management Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Population Health Management Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. U.S. Population Health Management Market: Product Estimates & Trend Analysis

  • 4.1. Segment Definition
  • 4.2. Product Movement Analysis & Market Share, 2024 & 2033
  • 4.3. U.S. Population Health Management Market: Product Segment Dashboard
  • 4.4. U.S. Population Health Management Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
    • 4.4.1. Software
      • 4.4.1.1. Software market estimates and forecast, 2021 - 2033 (USD Million)
    • 4.4.2. Services
      • 4.4.2.1. Services market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 5. U.S. Population Health Management Market: Delivery Mode Estimates & Trend Analysis

  • 5.1. Segment Definition
  • 5.2. Delivery Mode Movement Analysis & Market Share, 2024 & 2033
  • 5.3. U.S. Population Health Management Market: Delivery Mode Segment Dashboard
  • 5.4. U.S. Population Health Management Market Estimates & Forecasts, by Delivery Mode, 2021 to 2033 (USD Million)
    • 5.4.1. On-Premise
      • 5.4.1.1. On-Premise estimates and forecast, 2021 - 2033 (USD Million)
    • 5.4.2. Cloud-based
      • 5.4.2.1. Cloud-based estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. U.S. Population Health Management Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Definition
  • 6.2. End Use Movement Analysis & Market Share, 2024 & 2033
  • 6.3. U.S. Population Health Management Market: End Use Segment Dashboard
  • 6.4. U.S. Population Health Management Market Estimates & Forecasts by End Use, 2021 to 2033 (USD Million)
    • 6.4.1. Healthcare Providers
      • 6.4.1.1. Healthcare Providers market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.4.2. Payers
      • 6.4.2.1. Payers market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.4.3. Employer Groups
      • 6.4.3.1. Employer groups market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. U.S. Population Health Management Market - Competitive Analysis

  • 7.1. Participant Overview
  • 7.2. Financial Performance
  • 7.3. Product Benchmarking
  • 7.4. Company Categorization
  • 7.5. Company Market Position Analysis
  • 7.6. Company Profiles
    • 7.6.1. Veradigm LLC
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic Initiatives
    • 7.6.2. Oracle
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic Initiatives
    • 7.6.3. Conifer Health Solutions, LLC
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic Initiatives
    • 7.6.4. eClinicalWorks
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic Initiatives
    • 7.6.5. Enli Health Intelligence
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic Initiatives
    • 7.6.6. McKesson Corporation
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic Initiatives
    • 7.6.7. Medecision
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic Initiatives
    • 7.6.8. Optum, Inc.
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic Initiatives
    • 7.6.9. Advisory Board
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic Initiatives
    • 7.6.10. Koninklijke Philips N.V.
      • 7.6.10.1. Company overview
      • 7.6.10.2. Financial performance
      • 7.6.10.3. Product benchmarking
      • 7.6.10.4. Strategic initiatives
    • 7.6.11. athenahealth, Inc.
      • 7.6.11.1. Company overview
      • 7.6.11.2. Financial performance
      • 7.6.11.3. Product benchmarking
      • 7.6.11.4. Strategic initiatives
    • 7.6.12. RedBrick Health
      • 7.6.12.1. Company overview
      • 7.6.12.2. Financial performance
      • 7.6.12.3. Product benchmarking
      • 7.6.12.4. Strategic initiatives
    • 7.6.13. Welltok
      • 7.6.13.1. Company overview
      • 7.6.13.2. Financial performance
      • 7.6.13.3. Product benchmarking
      • 7.6.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 U.S. Population Health Management Market, By Product, 2021 - 2033 (USD Million)
  • Table 3 U.S. Population Health Management Market, By Delivery Mode, 2021 - 2033 (USD Million)
  • Table 4 U.S. Population Health Management Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. Population Health Management Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD Delivery modelling for market share assessment
  • Fig. 8 Market formulation validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment outlook
  • Fig. 11 Competitive scenario
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 U.S. Population Health Management Market: Product movement analysis
  • Fig. 17 U.S. Population Health Management Market: Product segment dashboard
  • Fig. 18 U.S. Population Health Management Market Product outlook: Key takeaways
  • Fig. 19 Software market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Population Health Management Market: Delivery Mode Outlook movement analysis
  • Fig. 22 U.S. Population Health Management Market: Delivery Mode Outlook segment dashboard
  • Fig. 23 U.S. Population Health Management Market: Delivery Mode Outlook: Key takeaways
  • Fig. 24 On-Premise market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Cloud-based market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. Population Health Management Market: End Use Outlook movement analysis
  • Fig. 27 U.S. Population Health Management Market: End Use Outlook segment dashboard
  • Fig. 28 U.S. Population Health Management Market: End Use Outlook: Key takeaways
  • Fig. 29 Healthcare Providers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Payers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Employer Groups market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Strategy Mapping